Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Heart Failure
  Free Subscription

Articles published in
Circ Res
    April 2024
  1. QASIM H, Rajaei M, Xu Y, Reyes-Alcaraz A, et al
    AKAP12 Upregulation Associates With PDE8A to Accelerate Cardiac Dysfunction.
    Circ Res. 2024;134:1006-1022.
    >> Share

    March 2024
  2. ECKLE T, Bertazzo J, Khatua TN, Fatemi Tabatabaei SR, et al
    Circadian Influences on Myocardial Ischemia-Reperfusion Injury and Heart Failure.
    Circ Res. 2024;134:675-694.
    >> Share

  3. CURAJ A, Vanholder R, Loscalzo J, Quach K, et al
    Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways.
    Circ Res. 2024;134:592-613.
    >> Share

    February 2024
  4. KAMRADT ML, Makarewich CA
    CHKB-DT: A Long Noncoding RNA Critical for Cardiovascular Health.
    Circ Res. 2024;134:442-444.
    >> Share

  5. VACCA A, Schiattarella GG
    From Gut to Heart: Role of Indole-3-Propionic Acid in HFpEF.
    Circ Res. 2024;134:390-392.
    >> Share

    January 2024
  6. WANG YC, Koay YC, Pan C, Zhou Z, et al
    Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction.
    Circ Res. 2024 Jan 24. doi: 10.1161/CIRCRESAHA.123.322381.
    >> Share

    December 2023
  7. STEGE NM, Eijgenraam TR, Oliveira Nunes Teixeira V, Feringa AM, et al
    DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters.
    Circ Res. 2023;133:1006-1021.
    >> Share

    November 2023
  8. DAI Z, Thorp EB
    New Way to Study Pulmonary Hypertension in HFpEF.
    Circ Res. 2023;133:899-901.
    >> Share

  9. AGRAWAL V, Kropski JA, Gokey JJ, Kobeck E, et al
    Myeloid Cell Derived IL1beta Contributes to Pulmonary Hypertension in HFpEF.
    Circ Res. 2023;133:885-898.
    >> Share

  10. KWAN Z, Paulose Nadappuram B, Leung MM, Mohagaonkar S, et al
    Microtubule-Mediated Regulation of beta(2)AR Translation and Function in Failing Hearts.
    Circ Res. 2023;133:944-958.
    >> Share

    October 2023
  11. LIU D, Wang M, Murthy V, McNamara DM, et al
    Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis.
    Circ Res. 2023;133:810-825.
    >> Share

    September 2023
  12. SERIO S, Pagiatakis C, Musolino E, Felicetta A, et al
    Cardiac Aging Is Promoted by Pseudohypoxia Increasing p300-Induced Glycolysis.
    Circ Res. 2023;133:687-703.
    >> Share

    July 2023

  13. Correction to: SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.
    Circ Res. 2023;133:e48.
    >> Share

  14. TANG X, Zhao S, Liu J, Liu X, et al
    Mitochondrial GSNOR Alleviates Cardiac Dysfunction via ANT1 Denitrosylation.
    Circ Res. 2023;133:220-236.
    >> Share

  15. DAI Y, Ignatyeva N, Xu H, Wali R, et al
    An Alternative Mechanism of Subcellular Iron Uptake Deficiency in Cardiomyocytes.
    Circ Res. 2023;133:e19-e46.
    >> Share

    June 2023
  16. FATKIN D, Ohanian M, Brown KJ
    A Novel Role for FKBP5 in Atrial Cardiomyopathy.
    Circ Res. 2023;133:45-47.
    >> Share

  17. SANCHEZ-ALONSO JL, Fedele L, Copier JS, Lucarelli C, et al
    Functional LTCC-beta(2)AR Complex Needs Caveolin-3 and Is Disrupted in Heart Failure.
    Circ Res. 2023 Jun 14. doi: 10.1161/CIRCRESAHA.123.322508.
    >> Share

    May 2023
  18. NAYAKANTI SR, Friedrich A, Sarode P, Jafari L, et al
    Targeting Wnt-ss-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling.
    Circ Res. 2023;132:1468-1485.
    >> Share

  19. BOULOS PK, Freeman SV, Henry TD, Mahmud E, et al
    Interaction of COVID-19 With Common Cardiovascular Disorders.
    Circ Res. 2023;132:1259-1271.
    >> Share

    April 2023
  20. NGUYEN TD, Schulze PC
    Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy.
    Circ Res. 2023;132:1034-1049.
    >> Share

  21. WU Z, Lohmoller J, Kuhl C, Wehrle K, et al
    Use of Computation Ecosystems to Analyze the Kidney-Heart Crosstalk.
    Circ Res. 2023;132:1084-1100.
    >> Share

    March 2023
  22. MATSUURA TR, Puchalska P, Crawford PA, Kelly DP, et al
    Ketones and the Heart: Metabolic Principles and Therapeutic Implications.
    Circ Res. 2023;132:882-898.
    >> Share

  23. YE S, Huang H, Han X, Luo W, et al
    Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling.
    Circ Res. 2023;132:707-722.
    >> Share

  24. CANNAVO A, Jun S, Rengo G, Marzano F, et al
    beta3AR-Dependent BDNF (Brain-Derived Neurotrophic Factor) Generation Limits Chronic Postischemic Heart Failure.
    Circ Res. 2023 Mar 8. doi: 10.1161/CIRCRESAHA.122.321583.
    >> Share

  25. HUGHES A, Shandhi MMH, Master H, Dunn J, et al
    Wearable Devices in Cardiovascular Medicine.
    Circ Res. 2023;132:652-670.
    >> Share

    February 2023
  26. YE B, Zhou H, Chen Y, Luo W, et al
    USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes.
    Circ Res. 2023;132:465-480.
    >> Share

  27. SAWICKI KT, De Jesus A, Ardehali H
    Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets.
    Circ Res. 2023;132:379-396.
    >> Share

  28. PI H, Xia L, Ralph DD, Rayner SG, et al
    Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes.
    Circ Res. 2023;132:254-266.
    >> Share

    January 2023
  29. EL JAMAL N, Lordan R, Teegarden SL, Grosser T, et al
    The Circadian Biology of Heart Failure.
    Circ Res. 2023;132:223-237.
    >> Share

  30. RUBINO M, Travers JG, Headrick AL, Enyart BT, et al
    Inhibition of Eicosanoid Degradation Mitigates Fibrosis of the Heart.
    Circ Res. 2023;132:10-29.
    >> Share

    December 2022
  31. LI Z, Xia H, Sharp TE 3rd, LaPenna KB, et al
    Hydrogen Sulfide Modulates Endothelial-Mesenchymal Transition in Heart Failure.
    Circ Res. 2022 Dec 28. doi: 10.1161/CIRCRESAHA.122.321326.
    >> Share

  32. DENG B, Zhang Y, Zhu C, Wang Y, et al
    Divergent Actions of Myofibroblast and Myocyte beta(2)-Adrenoceptor in Heart Failure and Fibrotic Remodeling.
    Circ Res. 2022 Dec 2. doi: 10.1161/CIRCRESAHA.122.321816.
    >> Share

    October 2022
  33. WU X, Liu H, Brooks A, Xu S, et al
    SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.
    Circ Res. 2022 Oct 24. doi: 10.1161/CIRCRESAHA.121.318988.
    >> Share

    September 2022

  34. Correction to: Mitochondrial H2S Regulates BCAA Catabolism in Heart Failure.
    Circ Res. 2022;131:e101.
    >> Share

  35. ZHANG J, Gutierrez-Lara EJ, Liang Y, Sheikh F, et al
    Functions Beyond the Editor's I in Regulating Cardiac Innate Immunity and Heart Failure.
    Circ Res. 2022;131:598-600.
    >> Share

  36. UMBARKAR P, Tousif S, Singh AP, Anderson JC, et al
    Fibroblast GSK-3alpha Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.
    Circ Res. 2022;131:620-636.
    >> Share

  37. GARCIA-GONZALEZ C, Dieterich C, Maroli G, Wiesnet M, et al
    ADAR1 Prevents Autoinflammatory Processes in the Heart Mediated by IRF7.
    Circ Res. 2022;131:580-597.
    >> Share

  38. TIAN C, Gao L, Rudebush TL, Yu L, et al
    Extracellular Vesicles Regulate Sympatho-Excitation by Nrf2 in Heart Failure.
    Circ Res. 2022 Sep 13:101161CIRCRESAHA122320916.
    >> Share

    August 2022

  39. Correction to: Heart Failure with Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models.
    Circ Res. 2022;131:e100.
    >> Share

    July 2022
  40. DOIRON JE, Lefer DJ
    Leveraging Adipocyte-Cardiomyocyte Signaling to Treat Ischemic Heart Failure.
    Circ Res. 2022;131:165-167.
    >> Share

    June 2022
  41. WANG X, Zhang G, Dasgupta S, Niewold EL, et al
    ATF4 Protects the Heart From Failure by Antagonizing Oxidative Stress.
    Circ Res. 2022;131:91-105.
    >> Share

  42. LI Z, Xia H, Sharp TE 3rd, LaPenna KB, et al
    Mitochondrial H2S Regulates BCAA Catabolism in Heart Failure.
    Circ Res. 2022 Jun 14:101161CIRCRESAHA121319817.
    >> Share

  43. PILZ PM, Ward JE, Chang WT, Kiss A, et al
    Large and Small Animal Models of Heart Failure With Reduced Ejection Fraction.
    Circ Res. 2022;130:1888-1905.
    >> Share

  44. ROH J, Hill JA, Singh A, Valero-Munoz M, et al
    Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models.
    Circ Res. 2022;130:1906-1925.
    >> Share

  45. BUGGER H, Byrne NJ, Abel ED
    Animal Models of Dysregulated Cardiac Metabolism.
    Circ Res. 2022;130:1965-1993.
    >> Share

    May 2022
  46. MICHEL T, Nougue H, Cartailler J, Lefevre G, et al
    proANP Metabolism Provides New Insights Into Sacubitril/Valsartan Mode of Action.
    Circ Res. 2022;130:e44-e57.
    >> Share

  47. ZHU D, Zhang Z, Zhao J, Liu D, et al
    Targeting Adiponectin Receptor 1 Phosphorylation Against Ischemic Heart Failure.
    Circ Res. 2022 May 25:101161CIRCRESAHA121319976.
    >> Share

  48. PATEL KP, Katsurada K, Zheng H
    Cardiorenal Syndrome: The Role of Neural Connections Between the Heart and the Kidneys.
    Circ Res. 2022;130:1601-1617.
    >> Share

  49. LIU J, Li W, Deng KQ, Tian S, et al
    The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy.
    Circ Res. 2022;130:1586-1600.
    >> Share

  50. TOMA A, Dos Santos C, Burzynska B, Gora M, et al
    Diversity in the Expressed Genomic Host Response to Myocardial Infarction.
    Circ Res. 2022 May 9:101161CIRCRESAHA121318391.
    >> Share

    April 2022

  51. Correction to: Heart Failure Subtypes and Cardiomyopathies in Women.
    Circ Res. 2022;130:e25.
    >> Share

  52. BRITTAIN EL, Hemnes AR
    Introduction to Review Series on Pulmonary Vascular Disease and Right Ventricular Heart Failure.
    Circ Res. 2022;130:1362-1364.
    >> Share

  53. HUSTON JH, Shah SJ
    Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
    Circ Res. 2022;130:1382-1403.
    >> Share

  54. ALENEZI F, Covington TA, Mukherjee M, Mathai SC, et al
    Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.
    Circ Res. 2022;130:1445-1465.
    >> Share

  55. BOUCHERAT O, Agrawal V, Lawrie A, Bonnet S, et al
    The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure.
    Circ Res. 2022;130:1466-1486.
    >> Share


  56. Correction to: The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.
    Circ Res. 2022;130:e23.
    >> Share

  57. MESUBI OO, Anderson ME
    Heart Failure and Atrial Fibrillation-Chicken or Egg?
    Circ Res. 2022;130:1011-1013.
    >> Share

    March 2022
  58. WANG J, Shi Q, Wang Y, Dawson LW, et al
    Gene Therapy With the N-Terminus of Junctophilin-2 Improves Heart Failure in Mice.
    Circ Res. 2022 Mar 23:CIRCRESAHA121320680. doi: 10.1161/CIRCRESAHA.121.320680.
    >> Share


  59. Correction to: Heart Failure Subtypes and Cardiomyopathies in Women.
    Circ Res. 2022;130:e21.
    >> Share

  60. STACHOWSKI-DOLL MJ, Papadaki M, Martin TG, Ma W, et al
    GSK-3beta Localizes to the Cardiac Z-Disc to Maintain Length Dependent Activation.
    Circ Res. 2022;130:871-886.
    >> Share

  61. YAO Y, Li F, Zhang M, Jin L, et al
    Targeting CaMKII-delta9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation.
    Circ Res. 2022;130:887-903.
    >> Share

  62. MA K, Yang J, Shao Y, Li P, et al
    Therapeutic and Prognostic Significance of Arachidonic Acid in Heart Failure.
    Circ Res. 2022 Mar 8:CIRCRESAHA121320548. doi: 10.1161/CIRCRESAHA.121.320548.
    >> Share

    February 2022
  63. DEFILIPPIS EM, Beale A, Martin T, Agarwal A, et al
    Heart Failure Subtypes and Cardiomyopathies in Women.
    Circ Res. 2022;130:436-454.
    >> Share

  64. KECELI G, Gupta A, Sourdon J, Gabr R, et al
    Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure.
    Circ Res. 2022 Feb 3:CIRCRESAHA121319648. doi: 10.1161/CIRCRESAHA.121.319648.
    >> Share

    January 2022
  65. SOSSALLA S, Bers DM
    Neuron-Restrictive Silencer Factor Limits Myocyte GalphaO Expression and Is Protective in Heart Failure Progression.
    Circ Res. 2022;130:249-251.
    >> Share

  66. SHEA S, Blaha MJ
    Long-Term Risk Prediction for Heart Failure, Disparities, and Early Prevention.
    Circ Res. 2022;130:210-212.
    >> Share

  67. INAZUMI H, Kuwahara K, Nakagawa Y, Kuwabara Y, et al
    NRSF-GNAO1 Pathway Contributes to the Regulation of Cardiac Ca(2+) Homeostasis.
    Circ Res. 2022;130:234-248.
    >> Share

    December 2021
  68. KHAN SS, Ning H, Allen NB, Carnethon M, et al
    Development and Validation of A Long-Term Incident Heart Failure Risk Model.
    Circ Res. 2021 Dec 10. doi: 10.1161/CIRCRESAHA.121.319595.
    >> Share

    October 2021

  69. Correction to: The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.
    Circ Res. 2021;129:e201.
    >> Share

  70. SOETKAMP D, Gallet R, Parker SJ, Holewinski R, et al
    Myofilament Phosphorylation in Stem Cell Treated Diastolic Heart Failure.
    Circ Res. 2021 Oct 13. doi: 10.1161/CIRCRESAHA.119.316311.
    >> Share

    September 2021
  71. WANG Y, Zhao M, Shi Q, Xu B, et al
    Monoamine Oxidases Desensitize Intracellular beta1AR Signaling in Heart Failure.
    Circ Res. 2021 Sep 17. doi: 10.1161/CIRCRESAHA.121.319546.
    >> Share

    August 2021
  72. RONG J, Tao X, Lin Y, Zheng H, et al
    Loss of Hepatic Angiotensinogen Attenuates Sepsis-Induced Myocardial Dysfunction.
    Circ Res. 2021;129:547-564.
    >> Share

    July 2021
  73. YURA Y, Miura-Yura E, Katanasaka Y, Min KD, et al
    The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.
    Circ Res. 2021 Jul 28. doi: 10.1161/CIRCRESAHA.121.319314.
    >> Share

  74. PADULA SL, Yutzey KE
    Epigenetic Regulation of Heart Failure: Cell Type Matters.
    Circ Res. 2021;129:414-416.
    >> Share

    June 2021
  75. HUO JL, Jiao L, An Q, Chen X, et al
    Myofibroblast Deficiency of LSD1 Alleviates TAC-Induced Heart Failure.
    Circ Res. 2021 Jun 3. doi: 10.1161/CIRCRESAHA.120.318149.
    >> Share

  76. GLASENAPP A, Derlin K, Gutberlet M, Hess A, et al
    Molecular Imaging of Inflammation and Fibrosis in Pressure Overload Heart Failure.
    Circ Res. 2021 Jun 2. doi: 10.1161/CIRCRESAHA.120.318539.
    >> Share

    May 2021
  77. AKAR FG, Young LH
    NAD Repletion Therapy: A Silver Bullet for HFpEF?
    Circ Res. 2021;128:1642-1645.
    >> Share

  78. RURIK JG, Aghajanian H, Epstein JA
    Immune Cells and Immunotherapy for Cardiac Injury and Repair.
    Circ Res. 2021;128:1766-1779.
    >> Share

  79. BURKE RM, Dirkx RA Jr, Quijada P, Lighthouse JK, et al
    Prevention of Fibrosis and Pathological Cardiac Remodeling by Salinomycin.
    Circ Res. 2021;128:1663-1678.
    >> Share

  80. FAN J, Li H, Xie R, Zhang X, et al
    LncRNA ZNF593-AS Alleviates Contractile Dysfunction in Dilated Cardiomyopathy.
    Circ Res. 2021;128:1708-1723.
    >> Share

  81. ROGER VL
    Epidemiology of Heart Failure: A Contemporary Perspective.
    Circ Res. 2021;128:1421-1434.
    >> Share

  82. NJOROGE JN, Teerlink JR
    Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure.
    Circ Res. 2021;128:1468-1486.
    >> Share

  83. LOPASCHUK GD, Karwi QG, Tian R, Wende AR, et al
    Cardiac Energy Metabolism in Heart Failure.
    Circ Res. 2021;128:1487-1513.
    >> Share

  84. HAHN VS, Zhang KW, Sun L, Narayan V, et al
    Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection.
    Circ Res. 2021;128:1576-1593.
    >> Share

  85. MANN DL, Felker GM
    Mechanisms and Models in Heart Failure: A Translational Approach.
    Circ Res. 2021;128:1435-1450.
    >> Share

  86. PAULUS WJ, Zile MR
    From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.
    Circ Res. 2021;128:1451-1467.
    >> Share

  87. MANN DL
    Heart Failure 2021: A Compendium of Translational Success.
    Circ Res. 2021;128:1419-1420.
    >> Share

  88. BURKHOFF D, Topkara VK, Sayer G, Uriel N, et al
    Reverse Remodeling With Left Ventricular Assist Devices.
    Circ Res. 2021;128:1594-1612.
    >> Share

    April 2021
  89. BLASER MC, Kraler S, Luscher TF, Aikawa E, et al
    Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis.
    Circ Res. 2021;128:1371-1397.
    >> Share

  90. TONG D, Schiattarella GG, Jiang N, Altamirano F, et al
    NAD(+) Repletion Reverses Heart Failure with Preserved Ejection Fraction.
    Circ Res. 2021 Apr 22. doi: 10.1161/CIRCRESAHA.120.317046.
    >> Share

  91. BOUTOUYRIE P, Chowienczyk P, Humphrey JD, Mitchell GF, et al
    Arterial Stiffness and Cardiovascular Risk in Hypertension.
    Circ Res. 2021;128:864-886.
    >> Share

    February 2021
  92. CHEN K, Wang S, Sun QW, Zhang B, et al
    Klotho Deficiency Causes Heart Aging via Impairing the Nrf2-GR Pathway.
    Circ Res. 2021;128:492-507.
    >> Share

  93. MUSTROPH J, Sag CM, Bahr F, Schmidtmann AL, et al
    Loss of CASK Accelerates Heart Failure Development.
    Circ Res. 2021 Feb 17. doi: 10.1161/CIRCRESAHA.120.318170.
    >> Share

  94. TAEGTMEYER H
    Heart Failure in Diabetes: Still a Vexing Problem.
    Circ Res. 2021;128:358-359.
    >> Share

  95. MANGNER N, Garbade J, Heyne E, van den Berg M, et al
    Molecular Mechanisms of Diaphragm Myopathy in Humans with Severe Heart Failure.
    Circ Res. 2021 Feb 1. doi: 10.1161/CIRCRESAHA.120.318060.
    >> Share

  96. LIU T, Yang N, Sidor A, O'Rourke B, et al
    MCU Overexpression Rescues Inotropy and Reverses Heart Failure by Reducing SR Ca(2+) Leak.
    Circ Res. 2021 Feb 1. doi: 10.1161/CIRCRESAHA.120.318562.
    >> Share

    January 2021
  97. EVANS MA, Walsh K
    A Single-Cell Analysis of DNMT3A-Mediated Clonal Hematopoiesis in Heart Failure.
    Circ Res. 2021;128:229-231.
    >> Share

  98. DENG Y, Xie M, Li Q, Xu X, et al
    Targeting Mitochondria-Inflammation Circuit by beta-Hydroxybutyrate Mitigates HFpEF.
    Circ Res. 2021;128:232-245.
    >> Share

  99. PERESTRELO AR, Silva AC, Oliver-De La Cruz J, Martino F, et al
    Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart.
    Circ Res. 2021;128:24-38.
    >> Share

  100. PAPA A, Kushner J, Hennessey JA, Katchman AN, et al
    Adrenergic CaV1.2 Activation via Rad Phosphorylation Converges at alpha1C I-II Loop.
    Circ Res. 2021;128:76-88.
    >> Share

    December 2020
  101. WITTENBECHER C, Eichelmann F, Toledo E, Guasch-Ferre M, et al
    Lipid Profiles and Heart Failure Risk: Results from Two Prospective Studies.
    Circ Res. 2020 Dec 4. doi: 10.1161/CIRCRESAHA.120.317883.
    >> Share

    November 2020
  102. ABPLANALP WT, Cremer S, John D, Hoffmann J, et al
    Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure.
    Circ Res. 2020 Nov 6. doi: 10.1161/CIRCRESAHA.120.317104.
    >> Share

    July 2020
  103. SHOEMAKER MB, Roden DM
    Atrial Fibrillation Is a Complex Trait: Very Complex.
    Circ Res. 2020;127:244-246.
    >> Share

    May 2020
  104. MARTINS-MARQUES T, Catarino S, Goncalves A, Miranda-Silva D, et al
    EHD1 Modulates Cx43 Gap Junction Remodeling Associated With Cardiac Diseases.
    Circ Res. 2020;126:e97-e113.
    >> Share

    March 2020
  105. JOLY JM, Tallaj JA
    The Heart of the (Gray) Matter Is not Black and White.
    Circ Res. 2020;126:765-766.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016